GSTM3 A/B polymorphism and risk for head and neck cancer: a meta-analysis.
about
A pharmacogenetic pilot study reveals MTHFR, DRD3, and MDR1 polymorphisms as biomarker candidates for slow atorvastatin metabolizers.Cytoprotective and regulatory functions of glutathione S-transferases in cancer cell proliferation and cell death.Gene-environment interactions in esophageal cancer.Glutathione S -transferase π: a potential role in antitumor therapy
P2860
GSTM3 A/B polymorphism and risk for head and neck cancer: a meta-analysis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
GSTM3 A/B polymorphism and risk for head and neck cancer: a meta-analysis.
@en
GSTM3 A/B polymorphism and risk for head and neck cancer: a meta-analysis.
@nl
type
label
GSTM3 A/B polymorphism and risk for head and neck cancer: a meta-analysis.
@en
GSTM3 A/B polymorphism and risk for head and neck cancer: a meta-analysis.
@nl
prefLabel
GSTM3 A/B polymorphism and risk for head and neck cancer: a meta-analysis.
@en
GSTM3 A/B polymorphism and risk for head and neck cancer: a meta-analysis.
@nl
P2093
P2860
P1433
P1476
GSTM3 A/B polymorphism and risk for head and neck cancer: a meta-analysis.
@en
P2093
P2860
P304
P356
10.1371/JOURNAL.PONE.0083851
P407
P577
2014-01-08T00:00:00Z